Our goal is to improve breast cancer treatment for all
Each year 2 million women are diagnosed with breast cancer and most will undergo some form of surgery.
Our goal is to develop technologies that allow physicians to give every one of those women a better standard of cancer care.
For each hospital that adopts our products, our hope is that more and more women with breast cancer can avoid surgery when it isn’t needed, and experience better outcomes when it is.
Our story
Endomag was founded in 2007 out of research conducted at the University College London (UCL) and the University of Houston.
We’ve grown from an academic research project into a global company with the belief that our technology can become the new standard of care across the world.
In 2024, Endomag was acquired by Hologic, a global leader in women's health. Our products are now routinely used by over 1,350+ hospitals in more than 45 countries. Over 500,000 women will have now accessed more precise and less invasive breast cancer treatment.
Our mission is to improve breast cancer care in three ways
Prevent unnecessary surgery
Supporting new advanced techniques that provide greater flexibility and de-escalate treatment.
Improve surgical outcomes
Giving physicians the tools to provide their patients with more precise, and less invasive surgery.
Increase patient access globally
With technologies that provide the best standard of care in any hospital around the world.
Our mission is to improve breast cancer care in three ways
Prevent unnecessary surgery
Supporting new advanced techniques that provide greater flexibility and de-escalate treatment.
Improve surgical outcomes
Giving physicians the tools to provide their patients with more precise, and less invasive surgery.
Increase patient access globally
With technologies that provide the best standard of care in any hospital around the world.
Trusted by physicians and patients globally
total patients treated
hospitals
countries globally
continents
clinical trials
Leadership team
Eric Mayes, PhD
Vice President, General Manager
Felicity Sartain, PhD
Chief Operations Officer
Quentin Harmer, PhD
Chief Technology Officer
Mathew Stephens
Chief Marketing Officer
Rob Hincks, FCCA
Chief Financial Officer
Anna Gourd
General Counsel
Stuart Devine
Chief Commercial Officer
